BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 17, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Sputnik V vaccine

Russia’s Sputnik V vaccine shows 92% efficacy in early phase III readout

Nov. 11, 2020
By Nuala Moran
LONDON – A second COVID-19 vaccine has reported positive results in an interim phase III analysis, with Russia’s Sputnik V showing 92% efficacy.
Read More
Digital cancer cells illustration

Varian injects $10M in Cota to fuel data-driven cancer care

Nov. 11, 2020
By Meg Bryant
Varian Medical Systems Inc. has invested $10 million in and inked a collaboration agreement with Cota Inc., a Boston-based curator of oncology clinical data. The radiation oncology company will now offer its customers access to Cota’s oncology real-world analytics and data curation services, which aggregate electronic health record (EHR) data to yield meaningful insights.
Read More
Regulatory front

ICER adjusts Veklury price models – again

Nov. 11, 2020
By Mari Serebrov
The latest global regulatory news, changes and updates affecting biopharma, including: MHRA advises on minimizing trial disruptions.
Read More

Regulatory actions for Nov. 11, 2020

Nov. 11, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Angiocrine, Bioxcel, Gyroscope, Inventiva, Sebela, Sorrento, Surface.
Read More

Other news to note for Nov. 11, 2020

Nov. 11, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agenus, Adaptive, Alcresta, Biontech, Biovaxys, Curis, Glaxosmithkline, Hebecell, Immuron Intellia, Myokardia, Nanoviricides, Oncimmune, Origimed, Parexel, PDS, Pfizer, Proteintech, Puretech, Recce, Reven, Revive, Takeda, Tiziana, Vapogenix, Xoma.
Read More

In the clinic for Nov. 11, 2020

Nov. 11, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AGTC, Ampio, Asieris, Blueberry, Cynata, Deciphera, Edgewise, Five Prime, Gyroscope, Henlius, Lineage, Lumos, Mesoblast, Oncternal, Pfizer, Prilenia, RDIF, Reven, Sagent, Xbrane.
Read More
Illustration of mouths coughing into hands

Quick cough tests reliably ID asymptomatic COVID-19, other conditions

Nov. 10, 2020
By Annette Boyle
As cases skyrocket and more questions arise about the high rate of false negatives returned by rapid testing in COVID-19 cases, a simple, new diagnostic test offers far greater accuracy. Researchers around the globe have found that artificial intelligence can detect coronavirus infections in recorded forced coughs, with nearly 100% accuracy in asymptomatic or presymptomatic cases, making it an ideal quick screening test. Forced cough or voice analysis shows strong results in other conditions, too, including pulmonary hypertension and, surprisingly, Alzheimer's disease.
Read More
Regulatory front

FDA announces class I recall of Stryker Trevo XP

Nov. 10, 2020
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CDC updates vaccine guidance; Russia launches doctor-driven shortage reporting service.
Read More

Regulatory actions for Nov. 10, 2020

Nov. 10, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biocartis, Icotec, Materialise, Medcad.
Read More

Other news to note for Nov. 10, 2020

Nov. 10, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anpac Bio-Medical Science, Applied DNA Sciences, Argentum Medical, Ascendum Solutions, Beckman Coulter, Bone Therapeutics, Casetabs, Contakt World Technologies, Dnanudge, Exergen, Foshion Dental, GE Healthcare, Genesiscare, Genosity, GT Medical Technologies, Hologic, Hst Pathways Systems & Technologies, Igentify, Intervenn Biosciences, Iremedy Healthcare Companies, Logicink, Luxcreo, Oxford Immunotec Global, Penumbra, Precision Genetics, Promaxo, Rapid AI, Speedx, Tscan Therapeutics, Wheeler Labs.
Read More
Previous 1 2 … 337 338 339 340 341 342 343 344 345 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Amyloid plaques on nerve cell

    Roche secures CE mark for Alzheimer’s blood test

    BioWorld
    Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing